Cenix BioScience GmbH Expands Relationship with AstraZeneca AB, Signing Multi-Project Research Agreement  
6/15/2009 8:56:29 AM

DRESDEN, Germany--(BUSINESS WIRE)--Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that they have signed a new multi-project research agreement with AstraZeneca, thereby expanding their relationship beyond its initial oncology focus, to now include respiratory and inflammation-related indications.